Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 70 citing articles:

The human antibody response to influenza A virus infection and vaccination
Florian Krammer
Nature reviews. Immunology (2019) Vol. 19, Iss. 6, pp. 383-397
Open Access | Times Cited: 626
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, et al.
Nature Medicine (2020) Vol. 27, Iss. 1, pp. 106-114
Open Access | Times Cited: 271
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer, Ron A. M. Fouchier, Maryna C. Eichelberger, et al.
mBio (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 249
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado, et al.
Molecular Therapy (2020) Vol. 28, Iss. 7, pp. 1569-1584
Open Access | Times Cited: 245
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses
Ali Zhang, Hannah D. Stacey, Caitlin E. Mullarkey, et al.
The Journal of Immunology (2019) Vol. 202, Iss. 2, pp. 335-340
Open Access | Times Cited: 187
Novel correlates of protection against pandemic H1N1 influenza A virus infection
Sophia Ng, Raffael Nachbagauer, Ángel Balmaseda, et al.
Nature Medicine (2019) Vol. 25, Iss. 6, pp. 962-967
Open Access | Times Cited: 171
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
Daniela S. Rajão, Daniel R. Pérez
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 137
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer, Peter Palese
Annual Review of Medicine (2019) Vol. 71, Iss. 1, pp. 315-327
Open Access | Times Cited: 121
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy, et al.
The Lancet Infectious Diseases (2019) Vol. 20, Iss. 1, pp. 80-91
Open Access | Times Cited: 120
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans
Haley L. Dugan, Jenna J. Guthmiller, Philip Arevalo, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 573
Open Access | Times Cited: 100
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
Hannah E. Maier, Raffael Nachbagauer, Guillermina Kuan, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 11, pp. 2290-2297
Open Access | Times Cited: 84
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Carolyn M. Boudreau, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains
Andrea N. Loes, Rosario Araceli L. Tarabi, John Huddleston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza
Xiaole Cui, Pieter Vervaeke, Ya Gao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Influenza and Antibody-Dependent Cellular Cytotoxicity
Tarra Von Holle, M. Anthony Moody
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 73
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Surender Khurana, Elizabeth M. Coyle, Jody Manischewitz, et al.
npj Vaccines (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 64
Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach
Weina Sun, Ericka Kirkpatrick, Megan E. Ermler, et al.
Journal of Virology (2019) Vol. 93, Iss. 12
Open Access | Times Cited: 63
Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
Florian Krammer, Jerry P. Weir, Othmar G. Engelhardt, et al.
Influenza and Other Respiratory Viruses (2019) Vol. 14, Iss. 2, pp. 237-243
Open Access | Times Cited: 62
Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus
Brenda Tesini, Preshetha Kanagaiah, Jiong Wang, et al.
Journal of Virology (2019) Vol. 93, Iss. 8
Open Access | Times Cited: 56
Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination
Rodrigo B. Abreu, Greg A. Kirchenbaum, Emily F. Clutter, et al.
JCI Insight (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 54
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains
Andrea N. Loes, Rosario Araceli L. Tarabi, John Huddleston, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Open Access | Times Cited: 5
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses
Claudia Maria Trombetta, Edmond J. Remarque, Daniëlla Mortier, et al.
Influenza and Other Respiratory Viruses (2018) Vol. 12, Iss. 6, pp. 675-686
Open Access | Times Cited: 57
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
Felix Broecker, Sean Liu, Nungruthai Suntronwong, et al.
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 49
Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus
Yun Zhang, Cong Xu, Hao Zhang, et al.
Viruses (2019) Vol. 11, Iss. 5, pp. 405-405
Open Access | Times Cited: 48
CD4+ follicular regulatory T cells optimize the influenza virus–specific B cell response
Yisi Lu, Ruoyi Jiang, Alec W. Freyn, et al.
The Journal of Experimental Medicine (2020) Vol. 218, Iss. 3
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top